Stereotaxis receives regulatory approval of Niobe tech in Japan

March 2013
Medical Device Daily;3/26/2013, Vol. 17 Issue 58, p2
The article informs that St. Louis-based Stereotaxis has reported that it has received regulatory approval of its Niobe remote magnetic technology for cardiac ablations in Japan. It states that approval will allows the company to begin marketing in establishing a local business infrastructure with in-country distributors. It also details that approval will also allow company working on obtaining reimbursement approval for full market entry, or the capability to lead sales. INSET: Coming Wednesday in MDD Perspectives.


Related Articles

  • Aetna: NanoKnife for ablation 'experimental'. Mccarthy, Mark // Medical Device Daily;7/24/2012, Vol. 16 Issue 142, p9 

    The article reports on a clinical policy bulletin from Aetna stating that the NanoKnife from Angiodynamics is not yet considered a prime tumor ablation device despite being granted a 510(k) from U.S. Food and Drug Administration (FDA) for ablation via irreversible electroporation.

  • BSD begins selling MicroThermX microwave ablation in Turkey.  // Medical Device Daily;12/9/2013, Vol. 17 Issue 236, p1 

    The article reports on the announcement by BSD Medical, a provider of medical systems that utilize heat therapy to treat cancer, in December 2013 that it has received a purchase order for multiple MicroThermX Microwave Ablation systems and antennas from ADA Medikal, its exclusive distributor in...

  • Med-Tech Notes.  // Medical Device Daily;4/11/2013, Vol. 17 Issue 70, p5 

    The article reports that Andain has started the testing of its miniature disposable insulin pump for the treatment of Type I and Type II diabetes for one week period.

  • VASCULAR SOLUTIONS WINS APPROVALS IN JAPAN.  // Medical Device Daily;12/16/2013, Vol. 17 Issue 241, p6 

    The article reports that two of Vascular Solutions' products, namely, the GuideLiner guide extension catheter and the SuperCross FT microcatheter, have received Shonin approval from the Japanese Ministry of Health, Labour and Welfare.

  • Veloxis' Phase 3 trial of LCP-Tacro in Stable Kidney Transplant Patients online in AJT.  // Transplant News;Jan2013, Vol. 23 Issue 1, p10 

    The article reports that Phase III trial of LCP-Tacro in stable kidney transplant patients, the 3001 study, by Veloxis Pharmaceuticals A/S has been published online in the American Journal of Transplantation (AJT).

  • Industry Pipeline.  // Ocular Surgery News;5/25/2014, Vol. 32 Issue 10, p30 

    This section offers news briefs on ocular surgery as of May 2014. It announces the U.S. Food and Drug Administration's (FDA) approval of the application from Hi-Tech Pharmacal for once-daily bromfenac ophthalmic solution 0.09 percent. Also reported are the 510(k) clearance received by Bausch +...

  • Industry Pipeline.  // Ocular Surgery News;6/25/2015, Vol. 33 Issue 12, p31 

    This section offers news briefs on the U.S. ophthalmic industry including the approval of Swiss-based medical company Alcon's new multifocal intraocular lens (IOL) for cataract treatment in U.S. patients by the U.S. Food and Drug Administration (FDA), the 501(k) clearance granted by the FDA to...

  • Seeking approval: For new drugs and devices, a faster track to market often found in Europe. Lee, Jaimy // Modern Healthcare;7/25/2011, Vol. 41 Issue 30, p30 

    The article discusses why drug companies and medical device manufacturers in the U.S. are focusing to market in Europe. According to Delcath President and chief executive officer (CEO) Eamonn Hobbs, there is a difficult regulatory environment in the U.S., making it difficult to bring new drug...

  • FDA 510(k) Recommendations: Overview of Comments and Next Steps. Lincoln, John E. // Journal of Validation Technology;Spring2011, Vol. 17 Issue 2, p47 

    "Device Validation Forum" discusses regulatory requirements, scientific principles, strategies, and approaches associated with medical device validation that are useful to practitioners. We intend this column to be a valuable resource for daily work applications.


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics